The main purpose of this study was to determine the prognostic status of patients with CLL by examining the common mutations in NOTCH1 and SF3B1 and their correlation with chromosomal abnormalities and clinical hematology. This evidence concerns the gene SF3B1 and B-cell chronic lymphocytic leukemia.